Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous cysteine glycinate is a chelated iron supplement composed of iron (II) complexed with the amino acids glycine and cysteine. It is used primarily as an iron source in dietary supplements and medical foods to treat or prevent iron deficiency and related anemia. The chelation with glycine and cysteine enhances the bioavailability of iron compared to traditional salts. Its mechanism of action involves providing elemental iron for absorption in the gastrointestinal tract, supporting hemoglobin synthesis and correcting or preventing states of low body iron[1][2][3]. Ferrous cysteine glycinate is found in products such as EnBrace HR, EnLyte, and AminoFerr[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous cysteine glycinate.